Latest news

Thumbnail image for NHS under ‘intolerable’ strain

NHS under ‘intolerable’ strain

NHS Confederation chief executive Niall Dickson is warning that the NHS is “under intolerable strain”, after the latest performance data continue to show growing demand and missed targets.

12th July 2018

Thumbnail image for Takeda gets US nod for Shire buy

Takeda gets US nod for Shire buy

Takeda says it has received unconditional clearance from the US Federal Trade Commission for the proposed acquisition of Shire.

10th July 2018

Thumbnail image for CTI, Servier’s Pixuvri fails in post-marketing trial

CTI, Servier’s Pixuvri fails in post-marketing trial

A late-stage trial of Servier and CTI BioPharma’s Pixuvri in combination with Roche's MabThera has failed to hit targets in B-cell non-Hodgkin lymphoma, putting its conditional approval in Europe in jeopardy.

10th July 2018

Thumbnail image for Three cancer treatments approved for use on NHS Scotland

Three cancer treatments approved for use on NHS Scotland

Three treatments have been approved for NHS funding in Scotland, bringing new options for gastroenteropancreatic tumours, lung and kidney cancers, but patients with multiple sclerosis will be unable to access Roche’s Ocrevus following a rejection by the SMC.

10th July 2018

Previous  --   4 5 6 7 8 9 10 11 12 13   --  Next

Latest jobs

View all

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download